2010
Building on in vitro characterization of a novel series of soluable gamma-secretase modulators (SGSMs) funded by Cure Alzheimer’s Fund, the current project is a thorough pharmacological or in vivo examination of these molecules to identify the best or “lead” drug candidate.
$250,000
Drug Development, Preclinical Drug Development
Rudy Tanzi, Ph.D.
Steven L. Wagner, Ph.D.
Liisa Galea, Annie Ciernia, | 2022
Mehdi Jorfi, Joseph Park, Rudy Tanzi, | 2021
Steven L. Wagner, | 2021
Raja Bhattacharyya, Rudy Tanzi, | 2021
Deepak Kumar Vijaya Kumar, Nanda Kumar Navalpur Shanmugam, Rudy Tanzi, William Eimer, | 2020
Steven L. Wagner, | 2020
Nanda Kumar Navalpur Shanmugam, Deepak Kumar Vijaya Kumar, Rudy Tanzi, William Eimer, | 2020
Ali Ezzati, Richard Lipton, | 2020